Published in Stroke on April 01, 1993
Lobar hemorrhages. Where do they come from? How do they get there? Stroke (1993) 1.44
Intracerebral haemorrhage. J Clin Pathol (1996) 0.76
Needle aspiration of an intracerebral hemorrhage complicating thrombolytic therapy for myocardial infarction. Stroke (1994) 0.75
Mental Dullness after thrombolytic therapy. Postgrad Med J (1997) 0.75
Cerebral Amyloid Angiopathy in Stroke Medicine. Dtsch Arztebl Int (2017) 0.75
Fluid levels in the bleeding brain: a marker for coagulopathy and hematoma expansion. Intern Emerg Med (2017) 0.75
Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology (2009) 7.04
Comparing predictors of conversion and decline in mild cognitive impairment. Neurology (2010) 5.69
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain (2009) 4.51
Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology (2000) 3.84
MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology (2009) 3.72
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology (2007) 3.24
MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology (2009) 2.83
MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology (2008) 2.69
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease. Neurology (2012) 2.68
Memory and MRI-based hippocampal volumes in aging and AD. Neurology (2000) 2.65
Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology (2008) 2.45
1H MR spectroscopy in common dementias. Neurology (2004) 2.39
APOE modifies the association between Aβ load and cognition in cognitively normal older adults. Neurology (2011) 2.35
Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology (2000) 2.26
Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology (2010) 2.20
Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology (2003) 2.10
Sequential magnetic resonance imaging following stereotactic radiofrequency ventralis lateralis thalamotomy. J Neurosurg (1991) 2.06
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology (2008) 2.01
Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology (2001) 1.92
Diffusion tensor imaging and cognitive function in older adults with no dementia. Neurology (2011) 1.89
Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol (1991) 1.89
Prospective multiaxial motion correction for fMRI. Magn Reson Med (2000) 1.88
Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects. Neurology (2010) 1.86
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology (2008) 1.80
Age-related changes in the default mode network are more advanced in Alzheimer disease. Neurology (2011) 1.75
Imaging correlates of pathology in corticobasal syndrome. Neurology (2010) 1.71
Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults. Neurology (2011) 1.70
MRI hippocampal volumes and memory function before and after temporal lobectomy. Neurology (1993) 1.68
Chronic divalproex sodium use and brain atrophy in Alzheimer disease. Neurology (2011) 1.66
Volumetric magnetic resonance imaging. Clinical applications and contributions to the understanding of temporal lobe epilepsy. Arch Neurol (1997) 1.66
Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology (1998) 1.64
Embolization of spinal dural arteriovenous fistula with polyvinyl alcohol particles: experience in 14 patients. AJNR Am J Neuroradiol (1992) 1.57
Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia. Neurology (2010) 1.57
Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology (2009) 1.48
Asymmetric cortical degenerative syndromes: clinical and radiologic correlations. Neurology (1992) 1.47
Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology (2010) 1.45
Dynamic MR digital subtraction angiography using contrast enhancement, fast data acquisition, and complex subtraction. Magn Reson Med (1996) 1.44
Magnetic resonance imaging of facial vascular anomalies. Mayo Clin Proc (1992) 1.41
Total intracranial volume: normative values and lack of association with Alzheimer's disease. Neurology (2002) 1.41
DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology (2005) 1.41
Predictors of outcome of anterior temporal lobectomy for intractable epilepsy: a multivariate study. Neurology (1998) 1.39
Factors predictive of the outcome of frontal lobe epilepsy surgery. Epilepsia (2000) 1.36
Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology (2009) 1.34
Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology (2009) 1.30
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry (2013) 1.30
Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology (2009) 1.28
Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration? Neurology (2010) 1.25
Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence. Radiology (1994) 1.24
Subtraction ictal SPET co-registered to MRI in partial epilepsy: description and technical validation of the method with phantom and patient studies. Nucl Med Commun (1998) 1.20
The anatomic correlate of prosopagnosia in semantic dementia. Neurology (2008) 1.18
Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations. Neurology (2009) 1.16
Contrast optimization of fluid-attenuated inversion recovery (FLAIR) imaging. Magn Reson Med (1995) 1.16
Interleaved echo planar imaging on a standard MRI system. Magn Reson Med (1994) 1.14
Assessment of functional MR imaging in neurosurgical planning. AJNR Am J Neuroradiol (1999) 1.14
Progressive hippocampal atrophy in chronic intractable temporal lobe epilepsy. Ann Neurol (1999) 1.13
Mapping of the central sulcus with functional MR: active versus passive activation tasks. AJNR Am J Neuroradiol (1998) 1.12
3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects. Neurobiol Aging (2010) 1.10
The significance of atypia and histologic malignancy in pilocytic astrocytoma of the cerebellum: a clinicopathologic and flow cytometric study. J Child Neurol (1994) 1.09
Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline. Neurobiol Aging (2010) 1.09
Subtraction SPECT co-registered to MRI improves postictal SPECT localization of seizure foci. Neurology (1999) 1.06
Imaging and biomarkers in early Alzheimer's disease and mild cognitive impairment. Clin Pharmacol Ther (2009) 1.06
Popliteal venous aneurysm as a source of pulmonary emboli in a male: case report. Angiology (1984) 1.05
Effects of age on the glucose metabolic changes in mild cognitive impairment. AJNR Am J Neuroradiol (2010) 1.04
Operative strategy in patients with MRI-identified dual pathology and temporal lobe epilepsy. Epilepsy Res (1993) 1.03
Discovery and replication of dopamine-related gene effects on caudate volume in young and elderly populations (N=1198) using genome-wide search. Mol Psychiatry (2011) 1.03
Real-time adaptive motion correction in functional MRI. Magn Reson Med (1996) 1.00
Hippocampal transverse relaxation times in patients with Alzheimer disease. Radiology (1997) 1.00
Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD. Neurology (2011) 0.99
Asymmetric cortical degeneration syndromes. A proposed clinical classification. Arch Neurol (1992) 0.98
Caudate atrophy on MRI is a characteristic feature of FTLD-FUS. Eur J Neurol (2010) 0.97
The management of intraosseous arteriovenous malformations in the head and neck area. Plast Reconstr Surg (1989) 0.96
EFNS task force: the use of neuroimaging in the diagnosis of dementia. Eur J Neurol (2012) 0.95
Bilateral magnetic resonance imaging-determined hippocampal atrophy and verbal memory before and after temporal lobectomy. Epilepsia (1996) 0.95
Significance of cerebellar atrophy in intractable temporal lobe epilepsy: a quantitative MRI study. Epilepsia (2000) 0.95
A prospective approach to correct for inter-image head rotation in fMRI. Magn Reson Med (1998) 0.94
Quantitative MRI hippocampal volumes: association with onset and duration of epilepsy, and febrile convulsions in temporal lobectomy patients. Epilepsy Res (1993) 0.94
MRI in the presurgical evaluation of patients with frontal lobe epilepsy and children with temporal lobe epilepsy: pathologic correlation and prognostic importance. Epilepsy Res (1992) 0.94
Routine EEG and temporal lobe epilepsy: relation to long-term EEG monitoring, quantitative MRI, and operative outcome. Epilepsia (1996) 0.93
Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN. Neurology (2011) 0.93
MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathology. Neurology (2010) 0.92
Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol (2013) 0.92
Primary intracerebral malignant lymphoma: a clinicopathological study of 89 patients. J Neurosurg (1995) 0.91
Electrocorticography and temporal lobe epilepsy: relationship to quantitative MRI and operative outcome. Epilepsia (1995) 0.90
New-onset seizures in critically ill patients. Neurology (1993) 0.87
Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain. Neuroimage (2010) 0.87
Pseudotumor syndrome associated with cerebral venous sinus occlusion and antiphospholipid antibodies. Stroke (1993) 0.87
T1-weighted MR imaging of the brain using a fast inversion recovery pulse sequence. J Magn Reson Imaging (1997) 0.86
Comparative diagnostic utility of 1H MRS and DWI in evaluation of temporal lobe epilepsy. Neurology (2002) 0.86
Comparative study of 99mTc-ECD and 99mTc-HMPAO for peri-ictal SPECT: qualitative and quantitative analysis. J Neurol Neurosurg Psychiatry (1999) 0.85
Determination of 10-20 system electrode locations using magnetic resonance image scanning with markers. Electroencephalogr Clin Neurophysiol (1993) 0.84
Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy. Eur J Neurol (2012) 0.84
Correlation of single photon emission CT with MR image data using fiduciary markers. AJNR Am J Neuroradiol (1993) 0.83
The relationship between quantitative T2 relaxometry and memory in nonlesional temporal lobe epilepsy. Epilepsia (2001) 0.83
Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology. Neurocase (2005) 0.83
Early childhood diagnosis of acoustic neuromas in presymptomatic individuals at risk for neurofibromatosis 2. Am J Med Genet (1991) 0.82
Primary progressive aphasia. An uncommon masquerader of psychiatric disorders. Psychosomatics (1994) 0.82
Gender differences in post-temporal lobectomy verbal memory and relationships between MRI hippocampal volumes and preoperative verbal memory. Epilepsy Res (1995) 0.82
Angiographic features of gliosarcoma. AJNR Am J Neuroradiol (1987) 0.82
Ultrasonic features of two cases of spinal cord hemangioblastoma. Surg Neurol (1986) 0.81
Polyvinyl alcohol sponge for embolotherapy: particle size and morphology. AJNR Am J Neuroradiol (1985) 0.81